InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,952.40
(
0.30%
)
Dow Jones
39,344.79
(
0.00%
)
Brent Oil
85.16
(
-0.30%
)
Bitcoin
57,473.59
(
1.35%
)
Post# of 252526
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: None

Monday, 06/28/2010 12:16:46 PM

Monday, June 28, 2010 12:16:46 PM

Post# of 252526
Bilski decision out:

http://www.supremecourt.gov/opinions/09pdf/08-964.pdf

The court (rightly in my view) rejected the patent as being simply an abstract idea, but importantly overturned the "machine or transformation" test that the lower court had devised. I'd say this is good for biotech testing patents (like Myriad's).

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up